SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-003728
Filing Date
2022-05-20
Accepted
2022-05-20 16:01:40
Documents
17
Period of Report
2022-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vnrx_8k.htm   iXBRL 8-K 29822
2 EXHIBIT 1.1 EQUITY DISTRIBUTION AGREEMENT vnrx_ex11.htm EX-1.1 271709
3 EXHIBIT 5.1 LEGAL OPINION AND CONSENT vnrx_ex51.htm EX-5.1 10703
9 vnrx_ex51img1.jpg GRAPHIC 2226
  Complete submission text file 0001477932-22-003728.txt   521793

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20220520.xsd EX-101.SCH 5830
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20220520_lab.xml EX-101.LAB 15320
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20220520_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20220520_pre.xml EX-101.PRE 9743
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20220520_def.xml EX-101.DEF 2103
11 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8k_htm.xml XML 3727
Mailing Address 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 22947502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances